Schultz, W. Neuronal reward and decision signals: from theories to data. Physiol. Rev. 95, 853–951 (2015).
Rubia, K. In Oxford Textbook of Attention Deficit Hyperactivity Disorder. 64–72 (Oxford University press, Oxford, 2018).
Verdejo-García, A., Lawrence, A. J. & Clark, L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci. Biobehav. Rev. 32, 777–810 (2008).
Breyer, J. L. et al. Young adult gambling behaviors and their relationship with the persistence of ADHD. J. Gambl. Stud. 25, 227–238 (2009).
Dekkers, T. J., Popma, A., van Rentergem, J. A. A., Bexkens, A. & Huizenga, H. M. Risky decision making in attention-deficit/hyperactivity disorder: a meta-regression analysis. Clin. Psychol. Rev. 45, 1–16 (2016).
Huys, Q. J., Maia, T. V. & Frank, M. J. Computational psychiatry as a bridge from neuroscience to clinical applications. Nat. Neurosci. 19, 404–13. (2016).
Mandali, A., Weidacker, K., Kim, S.-G. & Voon, V. The ease and sureness of a decision: evidence accumulation of conflict and uncertainty. Brain 142, 1471–1482 (2019).
Sethi, A., Voon, V., Critchley, H. D., Cercignani, M. & Harrison, N. A. A neurocomputational account of reward and novelty processing and effects of psychostimulants in attention deficit hyperactivity disorder. Brain 141, 1545–1557 (2018).
Forstmann, B. U., Ratcliff, R., & Wagenmakers, E.-J. Sequential sampling models in cognitive neuroscience: Advantages, applications, and extensions. Annu. Rev. Psychol. 67, 641–666 (2016).
Ziegler, S., Pedersen, M. L., Mowinckel, A. M. & Biele, G. Modelling ADHD: a review of ADHD theories through their predictions for computational models of decision-making and reinforcement learning. Neurosci. Biobehav. Rev. 71, 633–656 (2016).
Forstmann, B. U., Ratcliff, R. & Wagenmakers, E.-J. Sequential sampling models in cognitive neuroscience: advantages, applications, and extensions. Annu. Rev. Psychol. 67, 641–66 (2016).
Mulder, M., Van Maanen, L. & Forstmann, B. J. N. Perceptual decision neurosciences—a model-based review. Neuroscience 277, 872–884 (2014).
Aron, A. R., Dowson, J. H. Sahakian, B. J. & Robbins, T. W. Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry 54,1465–1468 (2003).
DeVito, E. E. et al. The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder. Biol. Psychiatry 64, 636–639 (2008).
Daw, N. D., Gershman, S. J., Seymour, B., Dayan, P. & Dolan, R. J. Model-based influences on humans’ choices and striatal prediction errors. Neuron 69, 1204–1215 (2011).
Gillan, C. M., Kosinski, M., Whelan, R., Phelps, E. A. & Daw, N. D. Characterizing a psychiatric symptom dimension related to deficits in goal-directed control. Elife 5, e11305 (2016).
Schultz, W. et al. Explicit neural signals reflecting reward uncertainty. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 363, 3801–3811 (2008).
Preuschoff, K., Bossaerts, P. & Quartz, S. R. Neural differentiation of expected reward and risk in human subcortical structures. Neuron 51, 381–390 (2006).
Wiecki, T.V., Sofer, I. & Frank, M. J. HDDM: Hierarchical Bayesian estimation of the drift-diffusion model in Python. Front. Neuroinform. 7, 14 (2013).
Krypotos, A.-M., Beckers, T., Kindt, M. & Wagenmakers, E.-J. A Bayesian hierarchical diffusion model decomposition of performance in Approach–Avoidance Tasks. Cognition Emot. 29, 1424–1444 (2015).
Frank, M. et al. Computational Psychiatry: New Perspectives on Mental Illness. Vol. 20 (MIT Press, 2016).
Advokat, C. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neurosci. Biobehav. Rev. 34, 1256–1266 (2010).
Pietras, C. J., Cherek, D. R., Lane, S. D., Tcheremissine, O. V. & Steinberg, J. L. Effects of methylphenidate on impulsive choice in adult humans. Psychopharmacology 170, 390–398 (2003).
Shiels, K. et al. Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Exp. Clin. Psychopharmacol. 17, 291–301 (2009).
Lopez-Persem, A., Domenech, P. & Pessiglione, M. How prior preferences determine decision-making frames and biases in the human brain. Elife 5, e20317 (2016).
Schonberg, T. et al. Decreasing ventromedial prefrontal cortex activity during sequential risk-taking: an fMRI investigation of the balloon analog risk task. Front. Neurosci. 6, 80 (2012).
Domenech, P., Redout, J., Koechlin, E. & Dreher, J.-C. The neuro-computational architecture of value-based selection in the human brain. Cereb. Cortex 28, 585–601 (2017).
Christakou, A., Brammer, M., Giampietro, V. & Rubia, K.J.J.O.N. Right ventromedial and dorsolateral prefrontal cortices mediate adaptive decisions under ambiguity by integrating choice utility and outcome evaluation. J. Neurosci. 29, 11020–11028 (2009).
Hartstra, E., Oldenburg, J., Van Leijenhorst, L., Rombouts, S. & Crone, E. A. Brain regions involved in the learning and application of reward rules in a two-deck gambling task. Neuropsychologia 48, 1438–1446 (2010).
Bechara, A., Damasio, H., Damasio, A.R. & Lee, G.P.J.J.O.N. Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. J. Neurosci. 19, 5473–5481 (1999).
Studer, B., Manes, F., Humphreys, G., Robbins, T. W. & Clark, L. Risk-sensitive decision-making in patients with posterior parietal and ventromedial prefrontal cortex injury. Cereb. Cortex 25, 1–9 (2013).
Hulvershorn, L.A. et al. Neural activation during risky decision-making in youth at high risk for substance use disorders. Psychiatry Res. 233, 102–111 (2015).
Spencer, R. C., Devilbiss, D. M. & Berridge, C. W. The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex. Biol. Psychiatry 77, 940–950 (2015).
Ojala, K.E. et al., Dopaminergic drug effects on probability weighting during risky decision making. eNeuro 5, ENEUEO.0330-18 (2018).
Rigoli, F. et al. Dopamine increases a value-independent gambling propensity. Neuropsycholpharmacology 41, 2658–2667 (2016).
Lopez-Guzman, S., Konova, A. B. & Glimcher, P. W. Computational psychiatry of impulsivity and risk: how risk and time preferences interact in health and disease. Philos. Trans. R. Soc. B 374, 20180135 (2019).
Wallsten, T. S., Pleskac, T. J. & Lejuez, C. W. Modeling behavior in a clinically diagnostic sequential risk-taking task. Psychological Rev. 112, 862 (2005).
Campbell-Meiklejohn, D. et al. In for a penny, in for a pound: methylphenidate reduces the inhibitory effect of high stakes on persistent risky choice. J. Neurosci. 32, 13032–13038 (2012).
Costa, A. et al. Methylphenidate effects on neural activity during response inhibition in healthy humans. Cereb. Cortex 23, 1179–1189 (2012).
Schmidt, A. et al. Comparative effects of methylphenidate, modafinil, and MDMA on response inhibition neural networks in healthy subjects. Int. J. Neuropsychopharmacol. 20, 712–720 (2017).
Pauls, A. M. et al. Methylphenidate effects on prefrontal functioning during attentional-capture and response inhibition. Biol. Psychiatry. 72, 142–149 (2012).
DeVito, E.E. et al. Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). Psychopharmacology (Berl). 202, 531–539 (2009).
Shalev, L., Gross-Tsur, V. & Pollak, Y. Single dose methylphenidate does not impact on attention and decision making in healthy medical students. J. Neurol. Res. 2, 227–234 (2013).
Gvirts, H. Z. et al. The effect of methylphenidate on decision making in patients with borderline personality disorder and attention-deficit/hyperactivity disorder. Int. Clin. Psychopharmacol. 33, 233–237 (2018).
Voon, V. et al. Waiting impulsivity: the influence of acute methylphenidate and feedback. Int. J. Neuropsychopharmacol. 19, pyv074 (2015).